Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials

Table 3 4^th Week clinical data

Laboratory Parameters	Iron Sucrose N = 93	Ferric Carboxymaltose N = 94	p value
Haemoglobin –– g/dL	11·59 ± 0·733	13·25 ± 0·606	0·0001
Mean Corpuscular Volume –– fL	86·76 ± 3·765	93·80 ± 3·380	0·0001
Serum Iron –– μg/dL	75·40 ± 6·223	127·54 ± 6·321	0·0001
Serum Ferritin –– μg/dL	34·99 ± 6·250	119·02 ± 5·487	0·0001
Total Iron Binding Capacity –– μg/dL	332·61 ± 18·619	315·13 ± 19·981	0·0001
Transferrin Saturation –– %	22·76 ± 2·183	40·59 ± 2·321	0·0001

ISSN: 1472-6874